Biosimilar Oncology Market - Quintile Research

Perjeta (pertuzumab) market size forecast 2026–2035 showing growth to USD 8.38 billion driven by HER2-positive breast cancer treatment demand.

Healthcare

Perjeta Market Set for Robust Growth Through 2035 Amid Clinical Advancements and Biosimilar Competition

Adarsh Mar 2, 2026 0

The global Perjeta market is poised for steady expansion over the next decade, driven by rising incidence of HER2-positive breast…

Read More

YOU MAY HAVE MISSED

Allergy Diagnostics Market forecast 2026–2035 showing growth from USD 7.09 billion to USD 20.51 billion driven by rising allergy prevalence and advanced molecular testing.

Healthcare

Allergy Diagnostics Market Set to Reach USD 20.51 Billion by 2035, Driven by Rising Global Allergy Burden

Adarsh Mar 2, 2026

Smart Therapeutic Devices Market forecast 2026–2035 showing growth from USD 86.57 billion to USD 308.35 billion driven by AI-enabled and connected medical devices.

Healthcare

Smart Therapeutic Devices Market to Surpass USD 308 Billion by 2035 Amid Rapid Digital Healthcare Transformation

Adarsh Mar 2, 2026

Perjeta (pertuzumab) market size forecast 2026–2035 showing growth to USD 8.38 billion driven by HER2-positive breast cancer treatment demand.

Healthcare

Perjeta Market Set for Robust Growth Through 2035 Amid Clinical Advancements and Biosimilar Competition

Adarsh Mar 2, 2026

Feminine Hygiene Products Market size and growth forecast 2026–2035 highlighting sustainable sanitary pads, tampons, and menstrual cups trends.

Healthcare

Feminine Hygiene Products Market to Reach USD 78.73 Million by 2035 Amid Sustainability and Innovation Push

Adarsh Feb 27, 2026